Ablation of Gprc6a in mice results in obesity, glucose intolerance, hepatic steatosis, sarcopenia and insulin resistance [6], and deletion of Ocn, a natural ligand for GPRC6A leads to an identical phenotype to Gprc6a-/- mice [7]. This evidence concerns the gene GPRC6A and obesity due to melanocortin 4 receptor deficiency.